1. Home
  2. NNDM vs MNPR Comparison

NNDM vs MNPR Comparison

Compare NNDM & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

HOLD

Current Price

$1.77

Market Cap

368.1M

Sector

Technology

ML Signal

HOLD

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$56.62

Market Cap

421.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNDM
MNPR
Founded
2012
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.1M
421.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
NNDM
MNPR
Price
$1.77
$56.62
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$101.42
AVG Volume (30 Days)
2.6M
305.3K
Earning Date
11-19-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$69,663,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
26.75
N/A
52 Week Low
$1.31
$26.06
52 Week High
$2.69
$105.00

Technical Indicators

Market Signals
Indicator
NNDM
MNPR
Relative Strength Index (RSI) 48.01 35.02
Support Level $1.77 $60.00
Resistance Level $1.97 $67.34
Average True Range (ATR) 0.10 4.84
MACD -0.01 -0.92
Stochastic Oscillator 26.42 5.84

Price Performance

Historical Comparison
NNDM
MNPR

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: